Todor Karaulanov

Todor Karaulanov is the Founder of Predigma Inc., a deep tech startup focused on introducing a New Paradigm in Medical Diagnostics and Treatment. Todor has developed non-invasive brain computer/machine interface (BCI/BMI) technology with unmatched spatial and temporal resolution.

Prior to founding Predigma Inc., Todor worked as the Chief Scientist at CaliberMRI since 2018. Todor has also served as the Chief Instrumentation Scientist at Imagion Biosystems, Inc from 2013 to 2018, where they worked on early in vivo detection of cancer.

Todor began their career as a Postdoctoral Researcher at Los Alamos National Laboratory from 2010 to 2013 and later at UC Berkeley from 2007 to 2010.

Todor Karaulanov pursued their education in the field of Physics, beginning with their undergraduate studies at Sofia University St. Kliment Ohridski. Todor attended the university from 1995 to 2001, earning a Master of Science (M.S.) degree.

Determined to further their knowledge and expertise in Physics, Todor Karaulanov then enrolled at the Bulgarian Academy of Sciences. Here, they embarked on a Ph.D. program, which they completed from 2001 to 2006. This period of intense study and research culminated in the successful completion of their doctoral studies and the attainment of a Ph.D. in Physics.

Based on the provided information, it can be concluded that Todor Karaulanov's educational journey involved obtaining a Master of Science degree from Sofia University St. Kliment Ohridski and a Ph.D. in Physics from the Bulgarian Academy of Sciences.